Aqumeldi 0.25 mg

Aqumeldi 0.25 mg is a medicine authorised by Swissmedic under authorisation number 70307. The authorisation holder is pharma services Oehler GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 December 2025 and the authorisation is limited until 10 December 2030. ATC code C09AA02 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 70307
  • ATC C09AA02
  • Synthetic medicines
Authorisation data
Authorisation number70307
NameAqumeldi 0.25 mg
Full nameAqumeldi 0.25 mg, Schmelztabletten
Authorisation holderpharma services Oehler GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09AA02
First authorisation11 December 2025
Authorisation validity10 December 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Aqumeldi 0.25 mg, SchmelztablettenB11 December 2025
2Aqumeldi 1 mg, SchmelztablettenB11 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
150Tablette(n)C09AA0202.07.1.B
2100Tablette(n)C09AA0202.07.1.B
3200Tablette(n)C09AA0202.07.1.B
450Tablette(n)C09AA0202.07.1.B
5100Tablette(n)C09AA0202.07.1.B
6200Tablette(n)C09AA0202.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Aqumeldi 0.25 mg authorised in Switzerland?

Yes. Aqumeldi 0.25 mg is authorised by Swissmedic under authorisation number 70307, data as of 01 September 2026. The authorisation is limited until 10 December 2030.

Which dispensing category does Aqumeldi 0.25 mg have?

Aqumeldi 0.25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Aqumeldi 0.25 mg?

The authorisation holder is pharma services Oehler GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com